Body shape

Cardiovascular Systems, Inc. Reports Fiscal 2021 Fourth Quarter and Full Year Financial Results

Retrieved on: 
Wednesday, August 4, 2021
Health, Surgery, Cardiology, Medical Devices, Clinical medicine, Health, Medicine, Cardiovascular diseases, Amphetamine, Bariatrics, Body shape, Nutrition, Obesity, Diabetes, Peripheral Artery Disease (PAD), Coronary Artery Disease (CAD), Cardiovascular Systems, Inc., PERIPHERAL ARTERY DISEASE (PAD), CORONARY ARTERY DISEASE (CAD), CARDIOVASCULAR SYSTEMS, INC.

With risk factors such as diabetes and obesity on the rise, the prevalence of PAD is growing at double-digit rates.

Key Points: 
  • With risk factors such as diabetes and obesity on the rise, the prevalence of PAD is growing at double-digit rates.
  • Stents are prone to fractures and high recurrence rates, and treatment of hard, calcified lesions often leads to vessel damage and suboptimal results.
  • CAD occurs when a fatty material called plaque builds up on the walls of arteries that supply blood to the heart.
  • See the instructions for use for detailed information regarding the procedure, indications, contraindications, warnings, precautions, and potential adverse events.

Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity

Retrieved on: 
Tuesday, July 27, 2021
Obesity, Articles, Life sciences, Nutrition, Bariatrics, Body shape, Epidemiology of obesity, Health sciences, Regeneron Pharmaceuticals, Medication

As published in Science , the new target was found by sequencing nearly 650,000 people and identifying individuals with rare protective mutations.

Key Points: 
  • As published in Science , the new target was found by sequencing nearly 650,000 people and identifying individuals with rare protective mutations.
  • "As experts on genetics and human biology, Regeneron is excited to join forces with the chemistry and small molecule leaders at AstraZeneca, as we seek to develop new medicines tackling the harmful and costly obesity epidemic."
  • "We are pleased to announce this important collaboration with Regeneron to identify small molecule modulators against GPR75, a newly identified target with genetic validation in metabolic disorders.
  • Worldwide the prevalence of obesity has more than tripled since 1975, and approximately 650 million adults are estimated to live with obesity today.

Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity

Retrieved on: 
Monday, July 26, 2021
Health, Clinical medicine, Congenital disorders, Pharmaceuticals policy, Amphetamine, Bariatrics, Body shape, Obesity, Appetite, Prader–Willi syndrome, Orphan drug

Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Tesomet for the treatment of hypothalamic obesity (HO).

Key Points: 
  • Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Tesomet for the treatment of hypothalamic obesity (HO).
  • Saniona is proud to be pioneering a regulatory path forward for people living with HO, and we are thrilled to have received the first-ever FDA orphan drug designation in HO.
  • Wood Foundation and parent of a child living with hypothalamic obesity, commented, The recognition of the first orphan drug designation in hypothalamic obesity is a critical milestone for the HO community.
  • Saniona is advancing Tesomet for hypothalamic obesity and Prader-Willi syndrome, two severe rare disorders characterized by obesity and loss of appetite control.

Global Weight Management Market Set for 8% CAGR During 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 22, 2021
Fitness & Nutrition, Health, Health, Clinical medicine, Nutrition, Human weight, Amphetamine, Bariatrics, Body shape, Obesity, Diabetes, Weight management

The "Weight Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Weight Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global weight management market exhibited moderate growth during 2015-2020.
  • This has led to rising occurrences of chronic diseases, such as diabetes, obesity, high cholesterol and heart attacks.
  • Looking forward, the global weight management market is expected to grow at a CAGR of around 8% during the forecast period (2021-2026).

Stop & Shop Becomes First Ever Grocery Retailer to Participate in the National Academy of Sciences’ Roundtable on Obesity Solutions

Retrieved on: 
Thursday, July 8, 2021
Bariatrics, Body shape, Nutrition, Amphetamine, Obesity, Medical specialties, Clinical medicine, Human body, Obesity in the United States

Stop & Shop is the first grocery retailer to join the NASEM Roundtable on Obesity Solutions and will work alongside experts from fields such as public policy, health, medicine, and education to develop sustainable, system-wide solutions to combat the obesity epidemic.

Key Points: 
  • Stop & Shop is the first grocery retailer to join the NASEM Roundtable on Obesity Solutions and will work alongside experts from fields such as public policy, health, medicine, and education to develop sustainable, system-wide solutions to combat the obesity epidemic.
  • More than 40% of American adults and nearly 20% of American children are affected by obesity, according to the CDC.
  • As a grocery retailer serving communities across the Northeast, Stop & Shop has a responsibility to do our part to help solve this national health crisis, said Gordon Reid, President of Stop & Shop.
  • Stop & Shop will participate in the Roundtable on Obesity Solutions through 2022 and beyond to help develop long-term strategies and solutions to reduce obesity and promote improved health outcomes in the communities it serves.

Trilliant Health Analysis Projects Flat to Declining Future Demand for Health Services, With Increasing Supply from New Market Entrants like Amazon and Walmart

Retrieved on: 
Monday, June 28, 2021
Managed care, Other Health, Radiology, Pharmaceutical, Oncology, Mental health, Medical devices, Hospitals, Surgery, Medical Supplies, Practice Management, Health, Physical therapy, Articles, Retailers, Retailing, Amphetamine, Bariatrics, Body shape, Nutrition, Obesity, Telehealth, Walmart

Moreover, future demand will not be meaningfully impacted by COVID-19 or by the increasing obesity of Americans, but primarily by population migration.

Key Points: 
  • Moreover, future demand will not be meaningfully impacted by COVID-19 or by the increasing obesity of Americans, but primarily by population migration.
  • The implications of softening demand and increasing supply suggest that pricing trends are ultimately unsustainable.
  • In addition, these trends confirm a key, but unreported, finding of the AAMC: the projected demand for surgeons has been declining for years.
  • Supply is rapidly increasing in commodity service offerings such as telehealth and urgent care, with new market entrants like Amazon and Walmart disrupting legacy delivery models.

DayTwo’s Solution for Obesity Delivers Sustained Weight Loss, BMI Reduction, and a Cost-Effective Alternative to Expensive Medications

Retrieved on: 
Thursday, June 24, 2021
Other Consumer, Diabetes, Fitness & Nutrition, Biotechnology, Other Health, Managed care, Health, Consumer, General Health, Obesity, Body shape, Health, Clinical medicine, Bariatrics, Branches of biology, Amphetamine, Nutrition, Weight loss

DayTwos unique solution for metabolic disease has meaningful and sustained clinical outcomes for employers, health systems, and health plans enabling a path to remission.

Key Points: 
  • DayTwos unique solution for metabolic disease has meaningful and sustained clinical outcomes for employers, health systems, and health plans enabling a path to remission.
  • After one year, participants sustain remarkable results including an average of:
    19 lbs of weight loss, and
    3.3 point drop in BMI.
  • DayTwos precision nutrition solution is offered at a critical time, as rates of obesity continue to skyrocket in the U.S.
  • Our sustained weight loss and BMI reduction results show that we are helping employees reach a healthy weight and get off expensive medications, said Josh Stevens, president of DayTwo.

Cats and Dogs Might Have Gained the "Covid 15," But New Data Reveals a Pet Obesity Epidemic Existed Long Before Quarantine

Retrieved on: 
Monday, June 21, 2021
Animals, Taxa, Organisms, Amphetamine, Bariatrics, Body shape, Nutrition, Obesity, Pet, Overweight, Dog, Obesity in pets

A wider look shines a spotlight on an even more concerning reality: diagnoses of overweight and obesity in cats and dogs have been occurring in epidemic proportions long before quarantine.

Key Points: 
  • A wider look shines a spotlight on an even more concerning reality: diagnoses of overweight and obesity in cats and dogs have been occurring in epidemic proportions long before quarantine.
  • "We want pet owners to know that you are not alone in managing your pet's weight.
  • It's clear from the data that many pets and their owners are struggling with this issue and Banfield is here to help."
  • Compared with pets of ideal weight, dogs and cats diagnosed as overweight or obese are more likely to suffer from other serious conditions.

ePallet Goes Back to School, Advocates for Cost-Effective Solutions to Reduce Childhood Obesity in the Classroom

Retrieved on: 
Monday, June 21, 2021
Bariatrics, Body shape, Childhood obesity, Health sciences, Obesity, Preventive healthcare, Toms River, New Jersey, Medicine, Health

"There's an immediate need to improve the quality of what students in grades K-12 are eating in school every day.

Key Points: 
  • "There's an immediate need to improve the quality of what students in grades K-12 are eating in school every day.
  • According to the Centers for Disease Control and Prevention , childhood obesity rates in the United States are rising and affect approximately 14.4 million children across the country.
  • "We chose ePallet because of the way ePallet modernizes the way we buy," said Peter Bratton,Director of Food Servicefor the Toms River, New Jersey, School District.
  • "Through ePallet, the platform allows for a much more convenient way for us to offer healthier options for our students.

NeonMind to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference

Retrieved on: 
Monday, June 14, 2021
Articles, Health sciences, Health, Amphetamine, Bariatrics, Body shape, Nutrition, Obesity, Medication, Wellness

Figure 1:NeonMind to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference

Key Points: 
  • Figure 1:NeonMind to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
    To view an enhanced version of Figure 1, please visit:
    H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference Details:
    The Company's presentation will be available on-demand at the start of the conference.
  • For more information regarding the conference or to schedule a one-on-one meeting with management, please contact KCSA Strategic Communications at [email protected] or your H.C. Wainwright representatives directly.
  • NeonMind is engaged in preclinical research to develop potential clinical treatments and wellness products to address obesity and weight management conditions and to promote health and wellness.
  • In its pharmaceutical division, NeonMind has two distinct psilocybin drug development programs targeting obesity.